APAC Topical Drug Delivery Market
In this report, APAC topical drug delivery market is expected to reach USD 34.1 billion by 2024, from USD 11.28 billion in 2016 growing at a CAGR of 14.9% in the forecast period 2017 to 2024.
Based on geography, the APAC topical drug delivery market is segmented into 11 geographical regions, such as,
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the APAC topical drug delivery market are
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
Based on geography, the APAC topical drug delivery market is segmented into 11 geographical regions, such as,
- Japan,
- China,
- South Korea,
- India,
- Australia,
- Singapore,
- Thailand,
- Malaysia,
- Indonesia,
- Philippines and
- Rest of APAC.
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the APAC topical drug delivery market are
- MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company),
- Crescita Therapeutics,
- West Pharmaceutical Services,
- Biofarmitalia s.r.l,
- Pharmatek Laboratories, Inc.,
- Stiefel Laboratories, Inc.,
- Tapemark, Acrux Limited,
- Nitto Denko Corporation,
- Skinvisible Pharmaceuticals, Inc.,
- Mylan Pharmaceuticals Inc.,
- Pocono Coated Products LLC,
- TheraSolve NV.,
- Samyang Biopharmaceuticals Corporation,
- Lohmann Therapie-Systeme AG,
- Prosollus Pharmaceuticals,
- Easton Pharmaceuticals Inc.,
- Novosis AG,
- Endo Pharmaceuticals Inc.,
- Transdermal Technologies, Inc.,
- Sheffield Pharmaceuticals, Inc.,
- Solvay
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
1. INTRODUCTION
1.1. OVERVIEW OF ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. ASIA PACIFIC ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. APAC TOPICAL DRUG DELIVERY MARKET
10.2.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.2.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.2.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.2.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.2.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.2.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.2.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.2.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.2.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.2.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.2.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET
11. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
TABLE LIST
TABLE 1 APAC TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
TABLE 2 APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 3 APAC TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 4 APAC TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 5 APACSEMI-SOLIDTOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 6 APAC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 7 APAC SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 8 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 9 ASIA PACIFIC ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 10 APAC TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 11 APAC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 12 JAPAN TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 13 JAPAN. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 14 JAPAN.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 15 JAPAN. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 16 JAPAN. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 17 JAPAN. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 18 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 19 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 20 CHINA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 21 CHINA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 22 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 23 CHINA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 24 CHINA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 25 CHINA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 26 CHINA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 27 CHINA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 28 SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 29 SOUTH KOREA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 30 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 31 SOUTH KOREA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 32 SOUTH KOREA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 33 SOUTH KOREA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 34 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE.35 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 36 INDIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 37 INDIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 38 INDIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 39 INDIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 40 INDIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 41 INDIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 42 INDIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024, (USD BILLION)
TABLE 43 INDIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 44 AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 45 AUSTRALIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 46 AUSTRALIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 47 AUSTRALIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 48 AUSTRALIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 49 AUSTRALIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 50 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 51 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 52 SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 53 SINGAPORE. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 54 SINGAPORE.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 55 SINGAPORE. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 56 SINGAPORE. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 57 SINGAPORE. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 58 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 59 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 60 THAILAND TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 61 THAILAND. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 62 THAILAND.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 63 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 64 THAILAND. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 65 THAILAND. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 66 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 67 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 68 MALAYSIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 69 MALAYSIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 70 MALAYSIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 71 MALAYSIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 72 MALAYSIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 73 MALAYSIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 74 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024, (USD BILLION)
TABLE 75 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 76 INDONESIA TOPICAL DRUG DELIVERY MARKET, BYTYPE, 2015 – 2024 (USD BILLION)
TABLE 77 INDONESIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 78 INDONESIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 79 INDONESIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 80 INDONESIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 81 INDONESIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 82 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 83 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 84 PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 85 PHILIPPINES. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 86 PHILIPPINES.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 87 PHILIPPINES. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 88 PHILIPPINES. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION
TABLE 89 PHILIPPINES. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 90 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 91 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 92 REST OF APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
1.1. OVERVIEW OF ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. ASIA PACIFIC ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. APAC TOPICAL DRUG DELIVERY MARKET
10.2.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.2.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.2.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.2.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.2.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.2.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.2.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.2.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.2.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.2.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.2.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET
11. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
TABLE LIST
TABLE 1 APAC TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
TABLE 2 APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 3 APAC TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 4 APAC TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 5 APACSEMI-SOLIDTOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 6 APAC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 7 APAC SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 8 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 9 ASIA PACIFIC ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 10 APAC TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 11 APAC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 12 JAPAN TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 13 JAPAN. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 14 JAPAN.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 15 JAPAN. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 16 JAPAN. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 17 JAPAN. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 18 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 19 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 20 CHINA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 21 CHINA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 22 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 23 CHINA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 24 CHINA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 25 CHINA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 26 CHINA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 27 CHINA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 28 SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 29 SOUTH KOREA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 30 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 31 SOUTH KOREA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 32 SOUTH KOREA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 33 SOUTH KOREA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 34 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE.35 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 36 INDIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 37 INDIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 38 INDIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 39 INDIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 40 INDIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 41 INDIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 42 INDIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024, (USD BILLION)
TABLE 43 INDIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 44 AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 45 AUSTRALIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 46 AUSTRALIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 47 AUSTRALIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 48 AUSTRALIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 49 AUSTRALIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 50 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 51 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 52 SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 53 SINGAPORE. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 54 SINGAPORE.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 55 SINGAPORE. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 56 SINGAPORE. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 57 SINGAPORE. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 58 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 59 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 60 THAILAND TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 61 THAILAND. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 62 THAILAND.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 63 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 64 THAILAND. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 65 THAILAND. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 66 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 67 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 68 MALAYSIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 69 MALAYSIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 70 MALAYSIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 71 MALAYSIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 72 MALAYSIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 73 MALAYSIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 74 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024, (USD BILLION)
TABLE 75 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 76 INDONESIA TOPICAL DRUG DELIVERY MARKET, BYTYPE, 2015 – 2024 (USD BILLION)
TABLE 77 INDONESIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 78 INDONESIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 79 INDONESIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 80 INDONESIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 81 INDONESIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 82 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 83 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 84 PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 85 PHILIPPINES. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 86 PHILIPPINES.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 87 PHILIPPINES. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 88 PHILIPPINES. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION
TABLE 89 PHILIPPINES. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 90 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 91 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 92 REST OF APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
FIGURES LIST
FIGURE 1 APAC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TOPICAL DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 2 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 3 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
FIGURE 4 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 5 ASIA PACIFIC TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
FIGURE 6 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
FIGURE 7 ASIA PACIFIC TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
COMPNIES PROFILES
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., Solvay
FIGURE 1 APAC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TOPICAL DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 2 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 3 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
FIGURE 4 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 5 ASIA PACIFIC TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
FIGURE 6 ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
FIGURE 7 ASIA PACIFIC TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
COMPNIES PROFILES
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., Solvay
